Relapsing peritonitis with Corynebacterium aquaticum in a boy receiving automated peritoneal dialysis.
Fujinaga
Shuichiro
S
Ohtomo
Yoshiyuki
Y
Hirano
Daishi
D
Nishizaki
Naoto
N
Someya
Tomonosuke
T
Ohtsuka
Yoshikazu
Y
Kaneko
Kazunari
K
Shimizu
Toshiaki
T
D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002437:Cefazolin / Q000627:therapeutic use; D002442:Ceftazidime / Q000627:therapeutic use; D003352:Corynebacterium / Q000187:drug effects / Q000302:isolation & purification*; D003354:Corynebacterium Infections / Q000188:drug therapy / Q000382:microbiology*; D004338:Drug Combinations; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D010538:Peritonitis / Q000188:drug therapy / Q000382:microbiology*; D012008:Recurrence; D016896:Treatment Outcome; D014640:Vancomycin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D014640:Vancomycin; D002442:Ceftazidime; D002437:Cefazolin